Accelerator to end TB in india

Amendment No. 4 to the subject BAA is issued to provide Questions and Answers and to extend the EOI submission date and time as follows:
1. Provide Questions and Answers. Refer to the attached Annex-1 for Questions and Answers.
2. Paragraph "I. Closing Date and Time for submittal of Expressions of Interest (EOI)" on Page 3 is revised to change the submission deadline to May 12, 2019 by 24:00 hours IST.
Amendment No. 3 to the subject BAA is issued to post the Webinar Presentation. The webinar was conducted on April 22, 2109..

Amendment No. 3 to the subject BAA is issued to post the Webinar Presentation. The webinar was conducted on April 22, 2109..

April 22, 2019:
Section H. of BAA No. BAA-ROAA-ENDTB-2019 on "Closing Date and Time for Submittal of Questions" is modified as follows:
1. Deadline for submitting Questions is now extended to April 24, 2019 at 24:00 hours Local time (Indian Standard Time).
2. Submitted Question/Answers will be posted at www.fbo.gov and www.grants.gov by April 29, 2019.
Paragraph H on Page 3 of the BAA is modified to include the email address for submittal of questions. All questions related to this BAA shall be submitted to indiarco@usaid.gov.
The United States Agency for International Development (USAID) is issuing this Broad Agency Announcement (BAA) to seek participants to co-create, co-design, co-invest, and collaborate on research and development interventions to rapidly demonstrate and rigorously test person-centered, high-impact and novel solutions that can accelerate the Government of India's (GOI) efforts to eliminate Tuberculosis (TB) by 2025. USAID invites organizations and companies to submit an Expression of Interest, as provided below.

Achieving the ambitious goal of ending TB by 2025 necessitates a paradigm shift in approach and strategy. Partnering with the GOI, USAID is calling for groundbreaking approaches to accelerate a reduction in TB, with a special focus on multidrug-resistant/rifampicin resistant TB MDR/RR-TB. USAID will invest in out-of-the-box, but achievable solutions that leapfrog conventional approaches to ensure a person-centered approach to prevent, diagnose and treat TB. USAID is particularly interested in investing in and supporting approaches that strengthen the enabling environment, enhance service delivery platforms and integrate the latest behavior change approaches with scientific and/or technological advances for maximum impact. Critical to the sustained success of the high-impact solutions is a defined understanding and pathway of how to ensure that TB services are accessible for all, including priority and vulnerable populations, and fostering diverse local partnerships that can help catalyze successful implementation.

The intent of the BAA is to allow co-creation and co-design to the maximum extent to create high quality, effective partnerships with great efficiency in time and resources. USAID will invite selected for-profit and non-profit, faith-based, public and private organizations, as detailed below, to co-create solutions to the Problem and Challenge Statements stated in this BAA, including those organizations that have ideas, expertise, resources, and/or funding to add to potential solutions.

Co-Investing: USAID wants to align goals with the partners under this BAA, to facilitate shared responsibility, shared risk, and shared resourcing. Shared resourcing requires that cash and other resources, both tangible and intangible, such as in-kind contributions, expertise, intellectual property, brand value, high-value coordination, and access to key people, places, and information, are directed towards reaching the solution to the Problem/Challenge. Co-investing does not require equal shared resources (such as 1:1 leverage), but rather resource contributions that are appropriate to the specific project's objectives, considering the comparative advantages brought by the participation of each party.

.

Paragraph H on Page 3 of the BAA is modified to include the email address for submittal of questions. All questions related to this BAA shall be submitted to indiarco@usaid.gov.
The United States Agency for International Development (USAID) is issuing this Broad Agency Announcement (BAA) to seek participants to co-create, co-design, co-invest, and collaborate on research and development interventions to rapidly demonstrate and rigorously test person-centered, high-impact and novel solutions that can accelerate the Government of India's (GOI) efforts to eliminate Tuberculosis (TB) by 2025. USAID invites organizations and companies to submit an Expression of Interest, as provided below.

Achieving the ambitious goal of ending TB by 2025 necessitates a paradigm shift in approach and strategy. Partnering with the GOI, USAID is calling for groundbreaking approaches to accelerate a reduction in TB, with a special focus on multidrug-resistant/rifampicin resistant TB MDR/RR-TB. USAID will invest in out-of-the-box, but achievable solutions that leapfrog conventional approaches to ensure a person-centered approach to prevent, diagnose and treat TB. USAID is particularly interested in investing in and supporting approaches that strengthen the enabling environment, enhance service delivery platforms and integrate the latest behavior change approaches with scientific and/or technological advances for maximum impact. Critical to the sustained success of the high-impact solutions is a defined understanding and pathway of how to ensure that TB services are accessible for all, including priority and vulnerable populations, and fostering diverse local partnerships that can help catalyze successful implementation.

The intent of the BAA is to allow co-creation and co-design to the maximum extent to create high quality, effective partnerships with great efficiency in time and resources. USAID will invite selected for-profit and non-profit, faith-based, public and private organizations, as detailed below, to co-create solutions to the Problem and Challenge Statements stated in this BAA, including those organizations that have ideas, expertise, resources, and/or funding to add to potential solutions.

Co-Investing: USAID wants to align goals with the partners under this BAA, to facilitate shared responsibility, shared risk, and shared resourcing. Shared resourcing requires that cash and other resources, both tangible and intangible, such as in-kind contributions, expertise, intellectual property, brand value, high-value coordination, and access to key people, places, and information, are directed towards reaching the solution to the Problem/Challenge. Co-investing does not require equal shared resources (such as 1:1 leverage), but rather resource contributions that are appropriate to the specific project's objectives, considering the comparative advantages brought by the participation of each party.

.

The United States Agency for International Development (USAID) is issuing this Broad Agency Announcement (BAA) to seek participants to co-create, co-design, co-invest, and collaborate on research and development interventions to rapidly demonstrate and rigorously test person-centered, high-impact and novel solutions that can accelerate the Government of India's (GOI) efforts to eliminate Tuberculosis (TB) by 2025. USAID invites organizations and companies to submit an Expression of Interest, as provided below.

Achieving the ambitious goal of ending TB by 2025 necessitates a paradigm shift in approach and strategy. Partnering with the GOI, USAID is calling for groundbreaking approaches to accelerate a reduction in TB, with a special focus on multidrug-resistant/rifampicin resistant TB MDR/RR-TB. USAID will invest in out-of-the-box, but achievable solutions that leapfrog conventional approaches to ensure a person-centered approach to prevent, diagnose and treat TB. USAID is particularly interested in investing in and supporting approaches that strengthen the enabling environment, enhance service delivery platforms and integrate the latest behavior change approaches with scientific and/or technological advances for maximum impact. Critical to the sustained success of the high-impact solutions is a defined understanding and pathway of how to ensure that TB services are accessible for all, including priority and vulnerable populations, and fostering diverse local partnerships that can help catalyze successful implementation.

The intent of the BAA is to allow co-creation and co-design to the maximum extent to create high quality, effective partnerships with great efficiency in time and resources. USAID will invite selected for-profit and non-profit, faith-based, public and private organizations, as detailed below, to co-create solutions to the Problem and Challenge Statements stated in this BAA, including those organizations that have ideas, expertise, resources, and/or funding to add to potential solutions.

Co-Investing: USAID wants to align goals with the partners under this BAA, to facilitate shared responsibility, shared risk, and shared resourcing. Shared resourcing requires that cash and other resources, both tangible and intangible, such as in-kind contributions, expertise, intellectual property, brand value, high-value coordination, and access to key people, places, and information, are directed towards reaching the solution to the Problem/Challenge. Co-investing does not require equal shared resources (such as 1:1 leverage), but rather resource contributions that are appropriate to the specific project's objectives, considering the comparative advantages brought by the participation of each party.

.